← Open Payments lookup

KSENIA NAWROCKI: Open Payments

NPI 1487882742 · CHULA VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,903 in 72 payments from 9 companies in 2025. Trend: 2023 $918 · 2024 $1,325 · 2025 $1,903

Food & beverage: $1,834Education: $70
CompanyPaymentsAmount
Alkermes, Inc.17$435
E.R. Squibb & Sons, L.L.C.15$424
Teva Pharmaceuticals USA, Inc.9$275
Vanda Pharmaceuticals Inc.6$189
ABBVIE INC.7$157
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$151
Janssen Pharmaceuticals, Inc5$106
Neurocrine BioSciences, Inc.4$87
Otsuka America Pharmaceutical, Inc.4$81

Products named: COBENFY, ARISTADA, UZEDY, FANAPT, VRAYLAR, CAPLYTA, LYBALVI, INVEGA SUSTENNA.

Industry payments across CA — which companies pay providers there.